| NAME OF THE PROJECT | : Sertraline Hydrochloride |
| PRODUCT NAME | : Sertraline USP Related Compound - A |
| CODE & CAT NO | : LP - 4450-03-006 |
| MOLECULAR FORMULA | : C17H18Cl3N |
| MOLECULAR WEIGHT | :342.69 |
| CAS NO | :79836-45-6 |
| CHEMICAL NAME | : (1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthalamine hydrochloride |
| CAT NO | : LP - 4450-01-001 |
| CAS NO | : 79559-97-0 |
| Mol.F | : C17H18Cl3N |
| Mol.Wt. | : 342.69 |
| CAT NO | : LP - 4450-03-006 |
| CAS NO | : 79836-45-6 |
| Mol.F | : C17H18Cl3N |
| Mol.Wt. | : 342.69 |
| CAT NO | : LP - 4450-03-003 |
| CAS NO | : 52758-05-1 |
| Mol.F | : C17H19N |
| Mol.Wt. | : 237.34 |
| CAT NO | : LP - 4450-03-004 |
| CAS NO | : 91797-63-6 |
| Mol.F | : C17H18ClN |
| Mol.Wt. | : 271.78 |
| CAT NO | : LP - 4450-03-002 |
| CAS NO | : 871838-58-3 |
| Mol.F | : C17H18ClN |
| Mol.Wt. | : 271.78 |
| CAT NO | : LP - 4450-03-007 |
| CAS NO | : 611-71-2 |
| Mol.F | : C8H8O3 |
| Mol.Wt. | : 152.14 |
| CAT NO | : LP - 4450-03-010 |
| CAS NO | : 155748-61-1 |
| Mol.F | : C16H12Cl2O |
| Mol.Wt. | : 291.17 |
| CAT NO | : LP-4450-03-008 |
| CAS NO | : 79617-95-1 |
| Mol.F | : C17H18Cl3N |
| Mol.Wt. | : 342.69 |
| CAT NO | : LP - 4450-03-006 |
| CAS NO | : 79836-45-6 |
| Mol.F | : C17H18Cl3N |
| Mol.Wt. | : 342.69 |
| CAT NO | : LP - 4450-03-001 |
| CAS NO | : 1198084-29-5 |
| Mol.F | : C17H17Cl2N |
| Mol.Wt. | : 206.23 |
| CAT NO | : LP - 4450-03-005 |
| CAS NO | : 152448-80-1 |
| Mol.F | : C16H12Cl2O |
| Mol.Wt. | : 291.17 |
| CAT NO | : LP - 4450-03-009 |
| CAS NO | : 79560-19-3 |
| Mol.F | : C16H12Cl2O |
| Mol.Wt. | : 291.17 |
CATEGORY : Sertraline Hydrochloride
TOTAL PRODUCTS : 12
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
